3K3A-APC / ZZ Biotech 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
3K3A-APC / ZZ Biotech
RHAPSODY-2, NCT05484154: Efficacy and Safety Evaluation of 3K3A-APC in Ischemic Stroke

Not yet recruiting
3
1400
NA
3K3A-APC, 3K3A-Activated Protein C, Placebo, Matching Placebo
ZZ Biotech, LLC, National Institute of Neurological Disorders and Stroke (NINDS), University of Southern California, University of Cincinnati, University of South Carolina
Ischemic Stroke
07/26
10/26
ACTRN12621000864820: 3K3A-APC for Treatment of Amyotrophic Lateral Sclerosis (ALS)

Completed
2
16
 
Macquarie University, Macquarie University
Amyotrophic Lateral Sclerosis, Motor Neuron Disease
 
 

Download Options